Αρχική World News EMA Recommends Granting a Marketing Authorisation for Vimseltinib World News EMA Recommends Granting a Marketing Authorisation for Vimseltinib Από Ogkologos - 5 Σεπτεμβρίου, 2025 321 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adults with symptomatic tenosynovial giant cell tumour Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Little Girl Declared Cancer-Free For The Holidays Following 2 Years Of... 24 Δεκεμβρίου, 2021 FDA Approves Gedatolisib with Fulvestrant, With or Without Palbociclib, for HR-positive,... 9 Σεπτεμβρίου, 2026 FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or... 2 Μαΐου, 2024 Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer 7 Ιανουαρίου, 2019 Φόρτωση περισσοτέρων HOT NEWS Death Rates from Ovarian Cancer will Fall in the EU and... 5 ways cancer can impact sexual wellbeing Woman, 88, Had Been Waving from Her Window for Over a... Outcomes of Cancer Patients with SARS-CoV-2 Infection in Veneto